Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof
    3.
    发明授权
    Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof 失效
    形成自聚集体的抗癌药物 - 壳聚糖复合物及其制备方法

    公开(公告)号:US07511023B2

    公开(公告)日:2009-03-31

    申请号:US10473629

    申请日:2002-08-14

    IPC分类号: A01N43/04 A61K31/70

    摘要: The present invention relates to an anticancer drug-chitosan complex forming self-aggregates and the preparation method thereof. More precisely, the present invention relates to the anticancer drug-chitosan complex forming self-aggregates in aqueous media composed of a hydrophobic anticancer agent and a hydrophilic chitosan, and the preparation method thereof. The anticancer drug-chitosan complex of the present invention not only works selectively against target tumor tissue but also continues to release the medicine over a long period of time. Besides, the anticancer drug-chitosan complex could have greater amount of drug by adding the anticancer drug into self-aggregates, which is generally limited by chemical bond. Therefore, the anticancer drug-chitosan complex of the present invention can be effectively used for the cancer chemotherapy.

    摘要翻译: 本发明涉及形成自聚集体的抗癌药物 - 壳聚糖复合物及其制备方法。 更准确地说,本发明涉及在由疏水性抗癌剂和亲水性壳聚糖组成的水性介质中形成自聚集体的抗癌药物 - 壳聚糖复合物及其制备方法。 本发明的抗癌药物 - 壳聚糖复合物不仅对目标肿瘤组织有选择性的作用,而且还能够长时间地释放药物。 此外,抗癌药物 - 壳聚糖复合物可以通过将抗癌药物加入自聚集体中而具有更大量的药物,其通常受化学键的限制。 因此,本发明的抗癌药物 - 壳聚糖复合物可以有效地用于癌症化疗。